GMXPX
Price
$22.93
Change
-$0.66 (-2.80%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

GMXPX vs RMFCX

Header iconGMXPX vs RMFCX Comparison
Open Charts GMXPX vs RMFCXBanner chart's image
Goldman Sachs Large Cp Val Insghts P
Price$22.93
Change-$0.66 (-2.80%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
GMXPX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GMXPX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMXPX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. GMXPX (508M). RMFCX pays higher dividends than GMXPX: RMFCX (1.69) vs GMXPX (1.35). GMXPX was incepted earlier than RMFCX: GMXPX (7 years) vs RMFCX (23 years). GMXPX is a more actively managed with annual turnover of: 208.00 vs. RMFCX (25.00). GMXPX has a lower initial minimum investment than RMFCX: GMXPX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. GMXPX (7.99). RMFCX return over 5 years is better than : 40.39 vs. GMXPX (13.93).
GMXPXRMFCXGMXPX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years23 years-
Gain YTD6.83811.42360%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets508M98.7B1%
Annual Yield % from dividends1.351.6980%
Returns for 1 year7.9912.6363%
Returns for 3 years7.8114.1655%
Returns for 5 years13.9340.3934%
Returns for 10 yearsN/A61.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc